BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 18683965)

  • 1. Proteomics-based identification of HSP60 as a tumor-associated antigen in early stage breast cancer and ductal carcinoma in situ.
    Desmetz C; Bibeau F; Boissière F; Bellet V; Rouanet P; Maudelonde T; Mangé A; Solassol J
    J Proteome Res; 2008 Sep; 7(9):3830-7. PubMed ID: 18683965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a new panel of serum autoantibodies associated with the presence of in situ carcinoma of the breast in younger women.
    Desmetz C; Bascoul-Mollevi C; Rochaix P; Lamy PJ; Kramar A; Rouanet P; Maudelonde T; Mangé A; Solassol J
    Clin Cancer Res; 2009 Jul; 15(14):4733-41. PubMed ID: 19584157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of the expression of the tumor suppressor gene ARHI is associated with progression of breast cancer.
    Wang L; Hoque A; Luo RZ; Yuan J; Lu Z; Nishimoto A; Liu J; Sahin AA; Lippman SM; Bast RC; Yu Y
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3660-6. PubMed ID: 14506155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomics-based identification of autoantibody against heat shock protein 70 as a diagnostic marker in esophageal squamous cell carcinoma.
    Fujita Y; Nakanishi T; Miyamoto Y; Hiramatsu M; Mabuchi H; Miyamoto A; Shimizu A; Takubo T; Tanigawa N
    Cancer Lett; 2008 May; 263(2):280-90. PubMed ID: 18334280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of tumor antigens that elicit a humoral immune response in breast cancer patients' sera by serological proteome analysis (SERPA).
    Hamrita B; Chahed K; Kabbage M; Guillier CL; Trimeche M; Chaïeb A; Chouchane L
    Clin Chim Acta; 2008 Jul; 393(2):95-102. PubMed ID: 18424265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
    Hildenbrand R; Schaaf A
    Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomics-based identification of alpha1-antitrypsin and haptoglobin precursors as novel serum markers in infiltrating ductal breast carcinomas.
    Hamrita B; Chahed K; Trimeche M; Guillier CL; Hammann P; Chaïeb A; Korbi S; Chouchane L
    Clin Chim Acta; 2009 Jun; 404(2):111-8. PubMed ID: 19306859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of MUC1 splice variants as prognostic markers in patients with ductal carcinoma in situ of the breast.
    Schmid BC; Rudas M; Fabjani G; Speiser P; Kaserer K; Leodolter S; Zeillinger R
    Oncol Rep; 2003; 10(6):1981-5. PubMed ID: 14534730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomics-based approach identifying autoantibody against peroxiredoxin VI as a novel serum marker in esophageal squamous cell carcinoma.
    Fujita Y; Nakanishi T; Hiramatsu M; Mabuchi H; Miyamoto Y; Miyamoto A; Shimizu A; Tanigawa N
    Clin Cancer Res; 2006 Nov; 12(21):6415-20. PubMed ID: 17085654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An autoantibody-mediated immune response to calreticulin isoforms in pancreatic cancer.
    Hong SH; Misek DE; Wang H; Puravs E; Giordano TJ; Greenson JK; Brenner DE; Simeone DM; Logsdon CD; Hanash SM
    Cancer Res; 2004 Aug; 64(15):5504-10. PubMed ID: 15289361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of AdipoR1 expression on breast cancer development.
    Pfeiler G; Hudelist G; Wülfing P; Mattsson B; Königsberg R; Kubista E; Singer CF
    Gynecol Oncol; 2010 Apr; 117(1):134-8. PubMed ID: 20071013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The HCCR oncoprotein as a biomarker for human breast cancer.
    Jung SS; Park HS; Lee IJ; Namkoong H; Shin SM; Cho GW; Ha SA; Park YG; Lee YS; Ko J; Kim JW
    Clin Cancer Res; 2005 Nov; 11(21):7700-8. PubMed ID: 16278390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies to Annexin XI-A and Other Autoantigens in the Diagnosis of Breast Cancer.
    Fernández-Madrid F; Tang N; Alansari H; Granda JL; Tait L; Amirikia KC; Moroianu M; Wang X; Karvonen RL
    Cancer Res; 2004 Aug; 64(15):5089-96. PubMed ID: 15289310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RUNX3 inactivation by frequent promoter hypermethylation and protein mislocalization constitute an early event in breast cancer progression.
    Subramaniam MM; Chan JY; Soong R; Ito K; Ito Y; Yeoh KG; Salto-Tellez M; Putti TC
    Breast Cancer Res Treat; 2009 Jan; 113(1):113-21. PubMed ID: 18256927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomics-based identification of alpha-enolase as a tumor antigen in non-small lung cancer.
    He P; Naka T; Serada S; Fujimoto M; Tanaka T; Hashimoto S; Shima Y; Yamadori T; Suzuki H; Hirashima T; Matsui K; Shiono H; Okumura M; Nishida T; Tachibana I; Norioka N; Norioka S; Kawase I
    Cancer Sci; 2007 Aug; 98(8):1234-40. PubMed ID: 17506794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phage display derived human monoclonal antibodies isolated by binding to the surface of live primary breast cancer cells recognize GRP78.
    Jakobsen CG; Rasmussen N; Laenkholm AV; Ditzel HJ
    Cancer Res; 2007 Oct; 67(19):9507-17. PubMed ID: 17909061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G-protein coupled receptor-associated sorting protein 1 (GASP-1), a potential biomarker in breast cancer.
    Tuszynski GP; Rothman VL; Zheng X; Gutu M; Zhang X; Chang F
    Exp Mol Pathol; 2011 Oct; 91(2):608-13. PubMed ID: 21791203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha 1-antitrypsin: a novel tumor-associated antigen identified in patients with early-stage breast cancer.
    López-Árias E; Aguilar-Lemarroy A; Felipe Jave-Suárez L; Morgan-Villela G; Mariscal-Ramírez I; Martínez-Velázquez M; Alvarez AH; Gutiérrez-Ortega A; Hernández-Gutiérrez R
    Electrophoresis; 2012 Jul; 33(14):2130-7. PubMed ID: 22821488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum autoantibody signature of ductal carcinoma in situ progression to invasive breast cancer.
    Mangé A; Lacombe J; Bascoul-Mollevi C; Jarlier M; Lamy PJ; Rouanet P; Maudelonde T; Solassol J
    Clin Cancer Res; 2012 Apr; 18(7):1992-2000. PubMed ID: 22322670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and validation of new autoantibodies for the diagnosis of DCIS and node negative early-stage breast cancers.
    Lacombe J; Mangé A; Jarlier M; Bascoul-Mollevi C; Rouanet P; Lamy PJ; Maudelonde T; Solassol J
    Int J Cancer; 2013 Mar; 132(5):1105-13. PubMed ID: 22886747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.